Navigation Links
New Blood Thinner Effient No Better Than Plavix at Preventing Heart Trouble: Study
Date:8/27/2012

By Amanda Gardner
HealthDay Reporter

SUNDAY, Aug. 26 (HealthDay News) -- The newer blood thinner Effient is no more effective than the widely used Plavix in preventing death, heart attacks or strokes, new research finds.

Nor is Effient (prasugrel) any safer than Plavix (clopidogrel) when it comes to bleeding complications in patients with acute coronary syndrome who have not had revascularization procedures such as bypass surgery or stenting.

The findings are scheduled to be presented Sunday at the European Society of Cardiology annual meeting in Munich and simultaneously published online in the New England Journal of Medicine.

The study was funded by Eli Lilly and Co. and Daiichi Sankyo Co., which co-developed Effient.

Acute coronary syndrome (ACS) includes heart attacks and other conditions, such as angina, which result from blocked coronary arteries.

Roughly 60 percent of patients with ACS undergo revascularization procedures to restore blood flow to the heart while the remaining 40 percent are managed by medications alone, the researchers said.

A previous trial of more than 13,000 ACS patients who were about to receive stents found that Effient was about 20 percent more effective than Plavix in preventing death, heart attacks and stroke. However, Effient also resulted in more cases of fatal bleeding.

This study was designed to look at a completely different group of ACS patients: those who did not undergo a revascularization procedure.

"This group of patients has never been exclusively studied before in a large-scale trial," said study author Dr. Matthew Roe, an associate professor of medicine at Duke University Medical Center in Durham, N.C.

Roe and other study authors reported financial ties with Eli Lilly, Daiichi Sankyo and other pharmaceutical companies.

For this study, 7,243 patients in 52 countries were randomized to receive 10 milligrams daily of Effient or 75 milligrams a day of Plavix. Both groups also took aspirin.

After an average follow-up of 17 months, 14 percent of patients receiving Effient died or had a heart attack or stroke, compared with 16 percent of those taking Plavix, not a statistically significant difference.

There was, however, some improvement in some health outcomes beyond the one-year mark in patients under the age of 75 taking Effient, the authors noted.

"There may be some patients who benefit for the longer term with platelet inhibitors," Roe said. "These patients that do not undergo revascularization may be fundamentally different from those who do [and] may need treatment longer. The exact reasons are not certain."

Plavix has the additional advantage of being inexpensive -- as little as about $35 for a month's supply since the drug went generic in May. Effient, on the other hand, can cost hundreds of dollars a month.

One expert noted that might make the difference when it comes to deciding which to prescribe for this group of patients.

"In the long run, it's going to come down to cost," said Dr. Christopher Cove, assistant director of the cardiac catheterization lab at the University of Rochester Medical Center. "Now that clopidogrel is generic, it's going to be tougher to prescribe a drug that's going to cost a lot more money without significant benefits."

More information

The Mayo Clinic has more on acute coronary syndrome.

SOURCES: Matthew Roe, M.D., associate professor, medicine, Duke University Medical Center, Durham, N.C.; Christopher Cove, M.D., associate professor, medicine, and assistant director, cardiac catheterization lab, University of Rochester Medical Center, New York; Aug. 26, 2012, New England Journal of Medicine, online; Aug. 26, 2012, presentation, European Society of Cardiology annual meeting, Munich


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Infection Might Raise Blood Clot Risk for Older Adults: Study
2. Normalizing tumor blood vessels improves delivery of only the smallest nanomedicines
3. Common Blood Pressure Drug Safe for Heart Failure: Study
4. Certain Birth Control Pills May Carry Higher Blood Clot Risk: FDA
5. High Blood Pressure May Be Especially Lethal for Blacks
6. Changes in gene expression may help explain high blood pressure in pregnancy
7. Researchers Develop Blood Test for Depression
8. Naturopathic care can improve blood sugar, mood in diabetes
9. Diabetes Groups Issue New Guidelines on Blood Sugar
10. Exercise May Help Patients With High Blood Pressure Live Longer
11. Additional blood pressure screening may reduce incidence of CVD events and death by up to 3 percent
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Blood Thinner Effient No Better Than Plavix at Preventing Heart Trouble: Study
(Date:5/24/2016)... ... ... Loma Linda University Health (LLUH) has officially broken ground on the hospital ... people looked on as the shovels hit the dirt at the community groundbreaking event ... the program, Richard H. Hart, MD, DrPH, president, LLUH, recapped the history of the ...
(Date:5/24/2016)... ... ... Boyd Industries, a leading supplier of dental chairs and cabinetry , ... pediatric dentistry , at AAPD 2016, the annual conference and trade show of the ... Unit keeps dental hand pieces and other anxiety-provoking pieces of the dental delivery system ...
(Date:5/24/2016)... ... May 24, 2016 , ... A newly released report reveals that ... access to trusted resources, both in face-to-face interactions and online. In “Heard, Not Judged ... concluded that the creative use of mobile digital devices can be an effective tool ...
(Date:5/24/2016)... ... May 24, 2016 , ... Growing in popularity, more and more people continue ... available and easily accessible. Whether someone chooses to cut gluten out of their life ... King Kullen Grocery stocks their shelves with many different gluten-free products all year round. ...
(Date:5/24/2016)... ... 24, 2016 , ... American Gene Technologies International, Inc ... its board of directors. Otterstatter is co-founder, president and CEO of Preventice, ... that lead to broad-based healthcare solutions. , “Jon knows how to create disruptive ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... UAE, May 23, 2016 Experts ... of Precision Medicine and the role of technology ...   The First International Conference of VPS-Penn Medicine ... distinguished patronage and presence of Sheikh Nahyan bin Mubarak Al ... in Precision Medicine, which helps provide personalized medicine and tailor-made ...
(Date:5/23/2016)... 23, 2016 The global  reprocessed ... billion by 2022, according to a new study by ... waste coupled with the lack of centralized support for ... drive the demand for reprocessed medical devices market. Additionally, ... to that of the original device is the high ...
(Date:5/22/2016)... DS Biopharma (DS) today ... compound DS102 in chronic obstructive pulmonary disease (COPD) ... patients. Recent DS preclinical data suggests ... and has bronchodilatory, anti-inflammatory and anti-fibrotic properties in ... will publish further detail on these findings later ...
Breaking Medicine Technology: